Back to Article

Differential Complete Blood Count for Diagnosis of COVID-19?

World Journal of Medical Microbiology | Vol 2, Issue 1

Table 3. A Comparison ofCurrent Presenting Symptoms between Case and Control Groups.

VariableCase GroupControl GroupTotalX2 ValueP Value (Sig)
Fever-ve15 (17.2%)29 (33.7%)44 (25.4%)6.1930.013
(Sig)
+ve72 (82.8%)57 (66.3%)129 (74.6%)
Cough-ve21 (24.1%)34 (39.5%)55 (31.8%)4.7280.03
(Sig)
+ve66 (75.9%)52 (60.5%)118 (68.2%)
Dyspnea-ve30 (34.5%)58 (67.4%)88 (50.9%)18.7980.000
(VHS)
+ve57 (65.5%)28 (32.6%)85 (49.1%)
Diarrhea-ve72 (82.8%)57 (66.3%)129 (74.6%)6.1930.013
(Sig)
+ve15 (17.2%)29 (33.7%)44 (25.4%)
Anosmia-ve66 (75.9%)86 (100%)152 (87.9%)23.6270.000
(VHS)
+ve21 (24.1%)0 (0%)21 (12.1%)
Sore Throat-ve66 (75.9%)76 (88.4%)142 (82.1%)4.6020.032
(Sig)
+ve21 (24.1%)10 (11.6%)31 (17.9%)
Vomiting-ve86 (98.9%)77 (89.5%)163 (94.2%)6.8910.009
(HS)
+ve1 (1.1%)9 (10.5%)10 (5.8%)

Sig: Significant VHS: Very highly Significant. HS: Highly Significant.